Breaking News

Cellevate to Prelaunch Nanofiber Microcarrier for Gene Therapy at CPHI Milan

Is designed to increase yield and productivity in upstream bioprocessing of gene therapy applications.

Author Image

By: Charlie Sternberg

Associate Editor

Cellevate, a biotech company developing next-generation cell culture systems to revolutionize biomanufacturing, will pre-launch the world’s first nanofiber microcarrier for gene therapy at CPHI Milan, October 8-10, 2024.   By providing up to 60 times more surface area for cell growth than conventional systems, Cellevat3d nanofiber microcarriers are designed to increase yield and productivity in upstream bioprocessing of gene therapy applications. Engineered for stirred tank bioreactors, Cellev...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters